Stony Brook Heart Institute’s Center for Advanced Lipid Management has achieved a historic global milestone, becoming the first center in the world to administer a commercial dose of plozasiran, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback